Clinical Trial Update: Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intranasal mupirocin for prevention of Staphylococcus aureus infections; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cross Infection
• Staphylococcal Infections

Drugs mentioned

• intranasal mupirocin (mupirocin)

Snippet

Sponsor: University Hospital Muenster | Conditions: Cross Infection, Staphylococcal Infections | Phase 4 | Status: COMPLETED